MindWalk Holdings (HYFT) Net Cash Flow Growth (3y) (2026)

MindWalk Holdings (HYFT) Net Cash Flow Growth (3y) (2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -8.34%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 36.60%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 106.37%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 114.55%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 4.55%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 67.39%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 52.78%
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2026 114.55%
Jan 31, 2026 -91.24%